Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05489965
Other study ID # UCDavis-1509981-2
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 31, 2023
Est. completion date June 1, 2025

Study information

Verified date October 2023
Source University of California, Davis
Contact Jasmine Cate
Phone 8582463035
Email jcate@health.ucsd.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To perform a multi-site prospective study assessing, both subjectively and objectively, the gender disparities in speech outcomes of patients using TEP after total laryngectomy. The investigators hypothesize that speech outcomes, both subjective and objective measures, will be significantly poorer for female patients compared to male patients. The outcome of the study is to prospectively assess both subjective and objective gender disparities in voice and speech outcomes of patients using TEP after total laryngectomy across a multiple institutions. The investigators hypothesize that both subjective and objective measurements of voice, speech and quality of life will be poorer for female patients in comparison to male patients.


Description:

Total laryngectomy (TL) is typically performed in patients with advanced laryngeal cancer as a means of removing the entire larynx and surrounding structures that have been affected by the malignancy. Following total laryngectomy, patients lose ability to produce voice. Thus, they require the use of alternative methods of to produce voice along with extensive speech rehabilitation. Currently, there are three main speech alternative options, esophageal speech, tracheoesophageal speech, and electrolarynx speech. The focus of this study will be on patients rehabilitating their speech using tracheosophgeal speech through a tracheoesophageal prosthesis (TEP). It has been shown that generally for TL patients, better voice quality and satisfaction with voice is associated with improved quality of life. Currently, speech rehabilitation outcomes are measured with a multidimensional approach, using various scales ranging from acoustic analysis, perceptual evaluation, and patient-reported outcomes. The majority of studies analyzing outcomes in total laryngectomy patients, however, is predominated by assessment of the male laryngectomee population. Historically, this has been due to the greater incidence of laryngeal cancers in males than females. Due to this, there has been minimal research investigating potential gender differences in the laryngectomy population. Of the limited data available regarding the female laryngectomee population, it has been shown that gender frequency differences seen in normal subjects are lost following total laryngectomy and the resulting tracheoesophageal voice is more similar to the normal male voice, thus females face a greater voice handicap compared to their male counterparts (Kazi, 2006; Deore, 2011). While some studies have assessed the resulting quality of life differences between the genders in the laryngectomy population (Lee, 2010), few have investigated voice outcomes using both subjective and objective scales as used in this study. The outcomes of this study will be key to understanding what metrics are potentially contributing to the voice and lifestyle dissatisfaction that prior studies have demonstrated in the female laryngectomee population. This quantifiable data will provide a way of modifying future voice rehabilitation in the female population to enable better satisfaction and minimize gender differences in voice outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 12
Est. completion date June 1, 2025
Est. primary completion date December 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Male and female subjects who have completed total laryngectomy and are using TEP Exclusion Criteria: - Subjects who have not completed total laryngectomy and are not using TEP

Study Design


Locations

Country Name City State
United States University of California San Diego La Jolla California

Sponsors (2)

Lead Sponsor Collaborator
University of California, Davis University of California, San Diego

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary FACT-H&N (Functional Assessment of Cancer Therapy - Head & Neck) Patient reported survey. Through study completion; 3 years (anticipate completion by June 2025)
Primary AVHI (Alaryngeal Voice Handicap Index) Patient reported survey. Through study completion; 3 years (anticipate completion by June 2025)
Secondary GRBAS - Grade, Roughness, Breathiness, Asthenia, and Strain Examiner-based interpretation of roughness/breathiness of patient's voice. Scale of 0-3, 3 indicating severe, 0 indicating normal Through study completion; 3 years (anticipate completion by June 2025)
Secondary Sustained phonation time A measurement in seconds of how long a patient can sustain phonation. Through study completion; 3 years (anticipate completion by June 2025)
Secondary Fundamental frequency A measurement of frequency of voice during alaryngeal speech/sustained phonation Through study completion; 3 years (anticipate completion by June 2025)
See also
  Status Clinical Trial Phase
Recruiting NCT02909088 - Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering). Phase 2/Phase 3
Recruiting NCT05695131 - Clinical Feasibility & Validation of the Virtual Reality GlenxRose Speech-Language Therapies N/A
Recruiting NCT04117360 - Orthognathic Speech Pathology: Phonetic Contrasts of Patients With Dental Discrepancies Pre- and Post-Treatment Analyses
Completed NCT02288598 - Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering N/A
Completed NCT02490826 - Table to Tablet (T2T): A Novel Intervention Framework for Children With Speech Sound Disorders N/A
Not yet recruiting NCT04528147 - Yi Jin Jing Tiger Roaring Speech Rehabilitation With Real-Time Feedback Technique for PD N/A
Completed NCT02554513 - Apraxia of Speech: Comparison of EPG Treatment (Tx) and Sound Production Treatment (SPT) N/A
Recruiting NCT05876247 - Articulatory Adaptation Following Oral Cancer Treatment
Completed NCT02752425 - Visual Feedback of Tongue by Ultrasound Echography for Speech Trouble Rehabilitation N/A
Recruiting NCT06443073 - The Mere-measurement Effect of Patient-reported Outcomes N/A
Recruiting NCT05741853 - Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia N/A
Completed NCT04026581 - Real World Testing of a Brain-Computer Interface
Active, not recruiting NCT04937452 - Dopaminergic Therapy for Frontotemporal Dementia Patients Phase 2
Completed NCT02416856 - Brain Connectivity Supporting Language Recovery in Aphasia
Completed NCT01180309 - Lingual Frenum and Articulation of Phonemes N/A
Completed NCT03663972 - Age-related Correlates of Treatment for Late-acquired Sounds N/A
Not yet recruiting NCT04323085 - Speech-in-Noise Treatments for Hypophonia in Parkinson's Disease Phase 2
Completed NCT00125242 - Word-Retrieval Treatment for Aphasia: Semantic Feature Analysis N/A
Completed NCT04966689 - The Effect of Combined Speech and Music-therapy on the Speech Characteristics of People With Parkinson's Disease (PD) N/A
Completed NCT04009811 - A New Membrane Obturator Prothesis Concept for Soft Palate Defects N/A